Publication | Closed Access
In vivo examination of 188Re(I)-tricarbonyl-labeled trastuzumab to target HER2-overexpressing breast cancer
33
Citations
10
References
2009
Year
Tumor BiologyBreast OncologyHer2-overexpressing Breast CancerMedicinePharmacologyCancer BiologyBreast CancerAnti-cancer AgentVivo ExaminationCancer TreatmentOncologyCell BiologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1